All very interesting and I thank everyone for the maximum effort in interpreting. the "affair" Acadia.
I try to give a reading on what happened and that above all it will happen on the market after this horrible week, because I consider it more important than ever at this time, look forward with the advantage now to relate what has come to light and what it has been said at least during the last year;
First of all, I do not think that Treagus is a trickster or a naive, so naïve as to wave the goodness of the agreement just signed up; the most interesting question to ask then is it because it is so enthused of this agreement ??? in addition, he always said that he was discussing with more international biotech and eventually chose the unfortunate Acadia, why ??? I fully understand the disappointment, but I absolutely do not believe that Treagus has settled on Acadia with the littleness and the consequent risks. it is in fact undeniable that behind Acadia there is one of the biggest star and strip inversers specialized in biotech. there are rumors never denied of a potential acquisition of Acadia by one of the largest American biotech companies. I absolutely do not believe that the contract with Acadia can be reduced to the handful of millions of dollars and even the complete release of Trofinetide and related unknowns after so many years of experimentation and support of well-known shareholders, including Australian government investment funds that until proven otherwise, a week ago, they never sold a single share of their portfolio. this last detail gives me the opportunity to explain from my point of view what happened on the market this week. Neuren, on the early morning of Tuesday, at still closed markets, notified the details of the agreement with Acadia; on the book immediately, as was already established, the price per share was set at $ 2 from $ 2.70 of the previous session. at the end of Tuesday's cursed session there were just over 2 million shares sold and 2.4 million shares bought at a further 20% lower leveling compared to the starting hypothesis price I mentioned. it can not be forgotten that for more than six months the price per share has not been split by the 3 $ and that obviously the agreement with Acadia had already more than one connotation,
so someone already had a management approach to the numbers on the market . and coincidentally, the 2 million shares ceded by Neuren arrive at the 4 $ per share exclusivity agreement; but according to you who is behind, or even more simply, who gives the money to Acadia to buy shares of Neuren ?? as I think the famous American funds referred to by Treagus and for which it was quickly realized the unification in order to promote their work.
said all this, between dietrology and suppositions, someone a bang to sold 2 million shares intentionally to $ 2 and then, by grace received the panic selling, repurchased the same in the same session, on average at $ 1.50. this suggests that chiuque has operated last Tuesday as a main activity this week, had in mind to sell and buy back its package of 2 million shares bought at $ 4 to get to have an average price charged of 3 $ (reference price of market in the last year). Usual tricks of those who work for the trade make the institutional that buys in assignment privately and then manages the market fiscally and strategically.
finally, if Treagus as it seems has framed this agreement as a great success, probably the company believes to have planned the best Trofinetide path to the advantage of something else. I expect shortly that the leadership will start to shift the focus on the future program net of receiving the 10 million Acadia account that may be worth much more for the purposes in which they will spend. as things are now there seems to be a strong intention to return the title to exchange first at 1.60 and then for logic that I tried to explain, at $ 2. I have great confidence that this will happen by next September and I want to continue to believe that it is a serious promise that one of the executives has indicated in the mails requested by the retail post-crisis when it talks about work in progress to re-evaluate the short-term title.
this is my reading of the facts.
Hello
- Forums
- ASX - By Stock
- Ann: Neuren and ACADIA announce agreement for North America
All very interesting and I thank everyone for the maximum effort...
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.33 |
Change
-0.240(1.45%) |
Mkt cap ! $2.087B |
Open | High | Low | Value | Volume |
$16.49 | $16.62 | $15.60 | $11.97M | 733.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 403 | $16.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.42 | 1763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 403 | 16.310 |
1 | 4130 | 16.240 |
2 | 1375 | 16.220 |
2 | 1763 | 16.200 |
1 | 1763 | 16.160 |
Price($) | Vol. | No. |
---|---|---|
16.420 | 1763 | 1 |
16.470 | 1763 | 1 |
16.500 | 100 | 1 |
16.510 | 1763 | 1 |
16.550 | 1763 | 1 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online